Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
MOXR0916, a humanized agonist anti-OX40 monoclonal antibody
/
mega-study
MOXR0916, a humanized agonist anti-OX40 monoclonal antibody